Daiichi Sankyo
Peter Lewek serves as the Associate Director of Learning & Development at Daiichi Sankyo, Inc. since November 2023. Prior to this role, Peter held various positions at Harvard Business School Executive Education from September 2013 to November 2023, including Operating Director for Custom Programs, where responsibilities encompassed overseeing operations for a portfolio serving over 70 client organizations and generating approximately $50 million in annual revenue. Peter's previous experience includes roles at TEDxEast and Metanexus Institute. Educational accomplishments include a Bachelor of Arts in Philosophy from Colgate University and the "Core: Credential of Readiness" from Harvard Business School Online.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.